Expectations and strategies regarding islet transplantation: Metabolic data from the GRAGIL 2 trial

Transplantation

Volumn 84, Issue 1, 2007, Pages 89-96

  Badet, Lionel ^a   Benhamou, Pierre Y ^b   Wojtusciszyn, Anne ^c   Baertschiger, Reto ^d   Milliat Guittard, Laure ^a   Kessler, Laurence ^e   Penfornis, Alfred ^f   Thivolet, Charles ^g   Renard, Eric ^c   Bosco, Dominico ^d   Morel, Philippe ^d   Morelon, Emmanuel ^a   Bayle, François ^b   Colin, Cyrille ^a   Berney, Thierry ^d  

^a University Hospital   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^f UNIVERSITY HOSPITAL OF BESANÇON   (France)

^g INSERM   (France)

Author keywords

Brittle diabetes; Multicentric network; Pancreatic islet transplantation; Type 1 diabetes mellitus

Indexed keywords

C PEPTIDE;

ADULT; AGED; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PANCREAS ISLET CELL; PRIORITY JOURNAL; PRODUCTIVITY; SEQUENTIAL ANALYSIS; TREATMENT OUTCOME;

EID: 34447645323     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000268511.64428.d8     Document Type: Article

References (29)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
3. Waugh N. Could fewer islet cells be transplanted in type 1 diabetes? BMJ 2000; 321: 1534.
4. Shapiro AM, Ryan EA, Warnock GL, et al. Could fewer islet cells be transplanted in type 1 diabetes? Insulin independence should be dominant force in islet transplantation. BMJ 2001; 322: 7290.
5. Benhamou PY, Oberholzer J, Toso C, et al. Humanislet transplantation network for the treatment of type 1 diabetes: First data from the Swiss-French GRAGIL consortium (1999-2000). Diabetologia 2001; 44: 859.
6. Kempf MC, Andres A, Morel P, et al. Logistics and transplant coordination activity in the Gragil swiss-french multicenter network of islet transplantation. Transplantation 2005; 79: 1200.
7. Kessler L, Bucher P, Milliat-Guittard L, et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network. Transplantation 2004; 77: 1301.
8. Baidal DA, Froud T, Ferreira JV, et al. The bag method for islet cell infusion. Cell Transplant 2003; 12: 809.
9. Ryan EA, Paty BW, Senior PA, et al. Beta-score: An assessment of β-cell function after islet transplantation. Diabetes Care 2005; 28: 343.
10. Bellissant E, Benichou J, Chastang C. Application of the triangular test to phase II cancer clinical trials. Stat Med 1990; 9: 907.
11. Kessler L, Lucescu C, Pinget M, et al. Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. Transplantation 2006; 81: 636.
12. Shapiro AM, Lakey JR, Paty BW, et al. Strategic opportunities in clinical islet transplantation. Transplantation 2005; 79: 1304.
13. Ricordi C, Inverardi L, Kenyon NS, et al. Requirements for success in clinical islet transplantation. Transplantation 2005; 79: 1298.
14. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
15. Korsgren O, Nilsson B, Berne C, et al. Current status of clinical islet transplantation. Transplantation 2005; 79: 1289.
16. American Diabetes Association. Diabetes Care 2004; 27: S105.
17. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741.
18. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
19. Goss JA, Schock AP, Brunicardi FC, et al. Achievement of insulin independence in three consecutive type 1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 2002; 74: 1761.
20. Goss JA, Goodpastor SE, Brunicardi FC, et al. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation 2004; 77: 462.
21. Lundgren T, Korsgren O, Foss A, et al. The Nordic Network for clinical islet transplantation - islet after kidney (IAK) - results and experiences from the first 44 transplantations. Transplantation 2004; 78(Suppl 2): 178.
22. National Institute of Heealth. NIH Implementation of the Recommendations of the Congressionally Directed Diabetes Research Working Group (2000). Available from http://www.niddk.nih.gov/federal/dwg/DRWGREP2.htm. Accessed 8 November 2006.
23. Luzi L, Perseghin G, Brendel MD, et al. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 2001; 50: 277.
24. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955.
25. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant 2006; 6: 371.
26. Sassa M, Fukuda K, Fujimoto S, et al. A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement. Diabetes Res Clin Pract 2006; 73: 235.
27. Ferrer-Garcia JC, Merino-Torres JF, Perez Bermejo G, et al. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice. Cell Transplant 2003; 12: 849.
28. Jorns A, Klempnauer J, Tiedge M, Lenzen S. Recovery of pancreatic beta cells in response to long-term normoglycemia after pancreas or islet transplantation in severely streptozotocin diabetic adult rats. Pancreas 2001; 23: 186.
29. Garcia-Ocana A, Vasavada RC, Takane KK, et al. Using beta-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 2001; 86: 984.